Edition:
United States

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

17.39USD
17 Feb 2017
Change (% chg)

$-0.10 (-0.60%)
Prev Close
$17.49
Open
$17.50
Day's High
$17.71
Day's Low
$17.15
Volume
75,792
Avg. Vol
91,145
52-wk High
$20.36
52-wk Low
$13.44

ATRC.OQ

Chart for ATRC.OQ

About

AtriCure, Inc. is a medical device company providing atrial fibrillation (Afib) solutions. The Company's segment develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. The Company has various product lines for... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $577.88
Shares Outstanding(Mil.): 33.24
Dividend: --
Yield (%): --

Financials

  ATRC.OQ Industry Sector
P/E (TTM): -- 34.11 29.39
EPS (TTM): -1.14 -- --
ROI: -18.78 12.43 13.06
ROE: -23.84 14.41 14.19

BRIEF-Atricure announces preliminary results

* Atricure announces preliminary results for fourth quarter and full year 2016

Feb 03 2017

BRIEF-Hudson Executive Capital reports 5.6 pct stake in AtriCure

* Hudson Executive Capital reports 5.6 pct stake In AtriCure Inc as of Jan 17 - sec filing

Jan 24 2017

BRIEF-AtriCure announces preliminary results for Q4 and FY 2016

* AtriCure announces preliminary results for fourth quarter and full year 2016

Jan 09 2017

BRIEF-Atricure names Sven Wehrwein to its board of directors

* Atricure names Sven Wehrwein to its board of directors Source text for Eikon: Further company coverage:

Nov 11 2016

BRIEF-Atricure announces approval for Cryoice(TM) platform in Japan

* Atricure announces approval for the cryoice(tm) platform in Japan

Nov 01 2016

BRIEF-Atricure Q3 loss per share $0.21

* Q3 earnings per share view $-0.28 -- Thomson Reuters I/B/E/S

Oct 27 2016

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $118.86 +0.78
St Jude Medical Inc (STJ.N) -- --

Earnings vs. Estimates